Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Apixaban composition and preparation method thereof

A technology of apixaban and apixaban tablets, applied in the field of apixaban pharmaceutical preparations

Inactive Publication Date: 2015-05-27
TIANJIN HANKANG PHARMA BIOTECH
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it was determined that formulations prepared using wet granulation methods as well as formulations prepared using large particles of the apixaban drug product yielded suboptimal exposures, which could create quality control challenges

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Apixaban composition and preparation method thereof
  • Apixaban composition and preparation method thereof
  • Apixaban composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0031] The dry granulation process for preparing crystalline apixaban granules having an average particle size equal to or less than about 70 μm is believed to be novel and is therefore provided as a further feature of the present invention. Therefore, the present invention provides a pharmaceutical product preparation method, comprising the following steps:

[0032] (1) blending the raw materials prior to granulation;

[0033] (2) Granulate the raw materials of step 1 using dry or wet granulation methods;

[0034] (3) blending the granules of step 2 with extragranular raw material;

[0035] (4) compressing the blend of step 3 into tablets; and

[0036] (5) Film-coat the tablets in step 4.

[0037] In another embodiment, the present invention provides a method for preparing a pharmaceutical product, comprising the steps of:

[0038] (1) blending the raw material with apixaban of controlled particle size;

[0039] (2) Including intragranular portions of binder, disi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Average particle sizeaaaaaaaaaa
D90aaaaaaaaaa
Login to View More

Abstract

The invention relates to an apixaban composition which contains crystalline apixaban particles with D90 equal to or smaller than 70 microns and a pharmaceutical carrier. The apixaban composition is basically bioequivalent and can be used for treating and / or preventing thromboembolic diseases.

Description

technical field [0001] The present invention relates to pharmaceutical formulations of apixaban comprising crystalline apixaban particles with a maximum size cutoff (cutoff), and methods of using them, e.g. for the treatment and / or prevention of thromboembolic disorders method. Background technique [0002] Apixaban is a known compound with the following structure: [0003] [0004] The chemical name of Apixaban is 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-piperidine- 1-yl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (CAS name) or 1-(4-methoxyphenyl)-7-oxo-6- [4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (IUPAC name). [0005] Apixaban is disclosed in U.S. Patent 6,967,208 (according to U.S. Patent Application 10 / 245,122 filed September 17, 2002), which is hereby incorporated by reference in its entirety, which has the clotting factor Use of Xa inhibitors, developed as oral administration for various in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/28A61K31/4545A61P7/02
Inventor 严洁李轩
Owner TIANJIN HANKANG PHARMA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com